Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort

Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome

(2011) Sofia Enhörning et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmö Diet and Cancer Study

(2011) Martin Magnusson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus

(2011) W. Fenske et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Plasma Copeptin and the Risk of Diabetes Mellitus

(2010) Sofia Enhörning et al.   CIRCULATION

Vasopressin V1a Receptor Polymorphism and Interval Walking Training Effects in Middle-Aged and Older People

(2010) Shizue Masuki et al.   HYPERTENSION

V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin–angiotensin system inhibition in rats with renal mass reduction

(2009) Norberto Perico et al.   KIDNEY INTERNATIONAL

Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort

(2009) Esther Meijer et al.   KIDNEY INTERNATIONAL

Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients

(2009) Esther Meijer et al.   TRANSPLANTATION

Relation between human vasopressin 1a gene variance, fat intake, and diabetes

(2008) Sofia Enhörning et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Copeptin in the Differential Diagnosis of Hyponatremia

(2008) Wiebke Fenske et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of C-Reactive Protein and Microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)

(2007) Abhijit V. Kshirsagar et al.   AMERICAN JOURNAL OF CARDIOLOGY